Association between tumor burden and response to immunotherapy in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Yasin, Hesham Abdallah
Chen, Yu-Wei
Tucker, Matthew D.
Beckermann, Katy
Schaffer, Kerry
Davis, Nancy B.
McAlister, Renee
Wallace, Deborah
Kaiser, Elizabeth
Rini, Brian I.
机构：
[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4541
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Treatment facility volume and survival in patients with metastatic renal cell carcinoma.
    Geynisman, Daniel M.
    Handorf, Elizabeth
    Zibelman, Matthew R.
    Plimack, Elizabeth R.
    Uzzo, Robert
    Kutikov, Alexander
    Smaldone, Marc C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [42] Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma.
    Bosse, Dominick
    Xie, Wanling
    Lalani, Aly-Khan A.
    de Velasco, Guillermo
    Voss, Martin Henner
    Tannir, Nizar M.
    Tamboli, Pheroze
    Appleman, Leonard Joseph
    Rathmell, Kimryn
    Heng, Daniel Yick Chin
    Sonpavde, Guru
    Signoretti, Sabina
    Hakimi, A. Ari
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [43] The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma.
    Mittal, Abhenil
    Al-Ezzi, Esmail Mutahar
    Li, Xuan
    Wilson, Brooke
    Spiliopoulou, Pavlina
    Sridhar, Srikala S.
    Fallah-Rad, Nazanin
    Chung, Peter W. M.
    Hamilton, Robert James
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [44] Sunitinb-induced hyperlipidemia in patients with metastatic renal cell carcinoma.
    Baldazzi, V.
    Tassi, R.
    Lapini, A.
    Carini, M.
    Mazzanti, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response
    Hajiran, A.
    Chakiryan, N.
    Aydin, A. M.
    Zemp, L.
    Nguyen, J.
    Laborde, J. M.
    Chahoud, J.
    Spiess, P. E.
    Zaman, S.
    Falasiri, S.
    Fournier, M.
    Teer, J. K.
    Dhillon, J.
    McCarthy, S.
    Moran-Segura, C.
    Katende, E. N.
    Sexton, W. J.
    Koomen, J. M.
    Mule, J.
    Kim, Y.
    Manley, B.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 204 (01): : 96 - 106
  • [46] Phenotypic differences in tumor-associated macrophages between metastatic and primary sites of clear cell renal cell carcinoma.
    Miura, Yuji
    Motoshima, Takanobu
    Wakigami, Nanako
    Kusada, Natsuki
    Okaneya, Toshikazu
    Inoshita, Naoko
    Takano, Toshimi
    Kamba, Tomomi
    Komohara, Yoshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [47] A study on the association between hyperlipidemia and hypothyroidism and the response to TKIs in metastatic renal cell carcinoma
    Song, Yan
    Du, Chunxia
    Zhang, Wen
    Sun, Yongkun
    Yang, Lin
    Cui, Chengxu
    Chi, Yihebali
    Shou, Jianzhong
    Zhou, Aiping
    Wang, Jinwan
    Sun, Yan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (02) : 174 - 180
  • [48] The impact of hypertension on response rates in patients with renal cell carcinoma.
    Maslov, Diana
    Tawagi, Karine
    Madhav, K. C.
    Goel, Richa
    Yuan, Helen
    Bamnolker, Adi
    Blake, Zoe
    Song, William
    Johnson, Daniel
    Matrana, Marc Ryan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [49] DIFFERENCE OF RESPONSE TO TARGETED THERAPY BETWEEN THE PRIMARY TUMOR AND METASTATIC LESIONS IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
    Nozawa, M.
    Matsumura, N.
    Yasuda, M.
    Okuda, Y.
    Uemura, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 231 - 232
  • [50] Re: Primary Tumor Response to Targeted Agents in Patients With Metastatic Renal Cell Carcinoma
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2011, 186 (06): : 2210 - 2210
12345